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In recent decades, we have witnessed dramatic reductions in
the mortality risk of acute myocardial infarction and, at the
same time, concerted and fruitful efforts to reduce length of
stay. In this issue, Senaratne et al. report the results of an
expanded strategy of early discharge, which included most
patients admitted to the Coronary/Intermediate Care Unit
(CICU) of the Grey Nuns Hospital in Edmonton, Canada
in 1995 and 1996 (1). Patients received usual medical care in
the CICU, but instead of being transferred to a general
medical unit when “stable,” eligible patients remained in the
CICU for a program of early ambulation, education and
direct discharge. Stable patients were allowed to walk in
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their rooms on hospital day two, encouraged to walk around
the CICU on day three and underwent low level exercise
testing on day four. In all, 414 of 479 patients (83%) were
discharged home from the CICU with a median length of
stay of 4 days. The remaining 65 patients either died in the
CICU or were transferred to other hospital units for
extended care. For the entire cohort of 479 patients, the
mean length of stay was 5.6 days. What is known about the
safety of early discharge following acute myocardial infarc-
tion, and how do the observations made by Senaratne and
his colleagues fit in?
In the era of reperfusion therapy for acute myocardial
infarction, efforts to reduce length of stay began when Eric
Topol and his colleagues at the University of Michigan
randomly assigned 80 patients with uncomplicated hospital
courses and no evidence of ischemia on a low level exercise
test performed on day three to discharge later on day three
or usual care (2). At 30 days, there were no deaths or
reinfarctions in the group assigned to early discharge.
Among those assigned to standard care, which usually
amounted to an additional five days in hospital, three
patients sustained reinfarction (p 5 NS). It is of note that
there were no adverse psychosocial consequences of early
discharge.
At about the same time, Sanz et al. conducted a feasibility
study of early discharge in 358 patients with Q-wave
myocardial infarction who were not treated with thrombo-
lytic therapy or primary angioplasty (3). On hospital day
four, 105 of these patients were free of heart failure,
recurrent ischemia or serious arrhythmias. Although con-
sidered eligible for early discharge, these patients remained
in the hospital for another 12 days, during which time there
were four deaths, one reinfarction, one serious arrhythmia,
one case of new onset congestive heart failure and eight
cases of recurrent chest pain. Multivariate analysis demon-
strated significant associations between age, diabetes and
ejection fraction less than 40% and these complications. In
a subsequent validation study, 67 of 122 patients with
Q-wave infarction not treated with reperfusion therapy were
clinically stable on hospital day four, and 18 of these
patients were still classified as low risk after adjustment for
age, diabetes, and ejection fraction ,40%. One of these
patients (5.6%) developed unstable angina over the ensuing
week; there were no deaths.
In 1994, Parsons et al. reported the results of a retrospec-
tive analysis of the clinical, electrocardiographic and enzy-
matic correlates of death in patients aged ,65 with acute
myocardial infarction (4). Among those aged ,60 without
previous history of myocardial infarction, diabetes, admis-
sion heart rate ,100, or significant Q waves on the
admission electrocardiogram, a subgroup comprising about
one third of the 6,746 patients in this large study, the
mortality rate at 30 days was a mere 0.8%. Although
congestive heart failure was not always factored directly into
the analysis, related variables, such as heart rate and creatine
kinase levels, were.
In a study that addresses the risk of early discharge more
directly, Wilkinson et al. analyzed the risk of major adverse
cardiac events (death, recurrent infarction, unstable angina
or ventricular fibrillation) occurring in 412 consecutive
patients with acute myocardial infarction but no clinical
evidence of heart failure (5). These patients accounted for
about 72% of all myocardial infarctions treated at a general
hospital, and most patients received thrombolytic therapy.
The estimated incidence of major adverse cardiac events was
5.9/1000 on hospital day 6, 3.4/1000 on day 10, and
0.9/1000 on day 21. The investigators estimated 3 deaths
and 3 reinfarctions per 1,000 patients without heart failure
between days 5 and 7. Because the study was retrospective,
it is not known whether these adverse outcomes were
preventable.
Newby et al. subsequently reported the incidence of major
adverse events among patients in GUSTO I who survived
the first four days of hospitalization without heart failure,
recurrent ischemia, defibrillation, cardioversion or revascu-
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larization (6). There were 23,497 patients, about 57% of the
total patient population, who met this definition of uncom-
plicated myocardial infarction. The in-hospital rate of
reinfarction (i.e., between day four and discharge) was 1.7%,
and the 30 day mortality rate was 1.0%. If discharged on day
three, this group would have had a reinfarction rate of 2.4%
and a mortality rate of 1.2%. If discharged on day five, the
figures would have been 1.3% and 0.9%. Quantitatively
similar results were reported from TAMI 1-3 (7).
Finally, Grines et al. reported the results of a randomized
clinical trial of transfer to a stepdown unit followed by
discharge on day four versus standard care in 471 patients
who had undergone successful primary angioplasty (8).
Eligible patients were aged ,70 years, had single or double
vessel coronary disease, ejection fraction .45% and no
serious arrhythmias. At six months, death or recurrent
infarction had occurred in 1.7% of accelerated care patients
and 0.9% of standard care patients (p 5 NS).
Most of the complications of acute myocardial infarction
occur in the first few days. Simple clinical variables, partic-
ularly the absence of heart failure, recurrent ischemia or
serious arrhythmias, can be used to define a low risk
population. Given the lack of published data demonstrating
the safety of early discharge in the elderly, and given their
higher complication rate, it may be appropriate to modify
plans for early discharge before applying them to the elderly,
but the literature does not clearly define either “elderly” or
the modifications that would be appropriate for this group.
Measurements of left ventricular function, low level predis-
charge stress testing, and coronary arteriography may be
used to refine risk stratification, but the cost effectiveness of
these approaches is not well characterized. In particular, it
should be noted that reinfarction and death, the complica-
tions of primary interest, may occur in the first week or two
after myocardial infarction despite efforts to define left
ventricular function and ischemic potential. Reinfarction
remains a largely unpredictable event (9), and a substantial
percentage of deaths occurring in otherwise uncomplicated
patients in the first week after myocardial infarction are due
to left ventricular free wall rupture (10).
In the present study, Senaratne et al. conclude that direct
discharge from the CICU is “a feasible and safe strategy for
the majority of patients.” In evaluating this approach, it is
useful to break the strategy down into two components and
analyze each separately. The first of these is a program of
early ambulation, the second an extension of criteria used to
define a population of patients suitable for early discharge.
Of early ambulation in the CICU, the authors state that
“very little was done while on the medical ward which could
not be achieved in an accelerated fashion within the [coro-
nary care unit].” This statement is indisputable, but inten-
sive care units are both labor and capital intensive, and with
proper staffing it may be possible to achieve the same result
for less money by combining one to three days in the
coronary care unit with one to three days in a stepdown or
telemetry unit. Thus, the location where this approach is
applied, which is fundamentally an administrative decision,
seems less important than the approach itself. As for the
approach, the authors stated only that all patients were
“mobilized in an accelerated fashion based on their clinical
condition and physical mobility.”
As many as 30% of patients with acute myocardial
infarction will experience some heart failure in the first four
days after myocardial infarction (5), and 40 to 50% will
experience heart failure, serious arrhythmias or recurrent
ischemia (6). Because 83% of patients in the present study
were discharged directly from the coronary care unit, it
would seem that patients with refractory heart failure,
arrhythmias or ischemia were excluded, whereas those
whose complications responded to initial therapy were
enrolled in the program of accelerated ambulation and early
discharge.
The results constitute a cautionary tale. At six weeks, the
mortality rate was 2.7%, with two of these deaths occurring
within 48 hours of discharge. The authors assert that “this
[mortality rate] cannot be considered excessive,” but in the
absence of evidence that these deaths were unpreventable, a
mortality rate of 2.7% at six weeks in a low risk group should
be considered excessive. This mortality rate compares to a
mortality rate of 1% between days 4 and 30 in over 23,000
low risk patients from GUSTO I (6) and a 30 day mortality
rate of 0.8% in over 2,000 low-risk patients in the study by
Parsons et al. (4). Senaratne et al. do not report the
reinfarction rate, but they do tell us that unscheduled return
visits occurred in 4% by 48 hours and in 28% by 6 weeks. In
total, 8% of the early discharge patients were readmitted to
the hospital within 6 weeks. Unscheduled return visits were
not associated with congestive heart failure or recurrent
ischemia during the hospital phase, but this observation
seems most likely due to a lack of power, because other,
larger studies have consistently identified heart failure and
recurrent ischemia as powerful predictors of late complica-
tions. In GUSTO I, for example, patients with complica-
tions in the first four days had a mortality rate of 8.9%
between days 4 and 30, and the in-hospital reinfarction rates
were 2.2 and 1.7%, respectively, for patients with and
without complications in the first four days (6).
Judging the safety of any treatment strategy is often a
complex matter, influenced as much by tradition as by
reason. In the absence of data from randomized clinical
trials that demonstrate that certain deaths and reinfarctions
occurring in the first week or two after myocardial infarction
are unpreventable, patients with heart failure, serious ar-
rhythmias or recurrent ischemia occurring in the first three
or four days after admission should not be considered
low-risk, even if they respond to initial therapy. Such
patients should not be considered suitable for early dis-
charge unless definitive therapy (e.g., angioplasty for recur-
rent ischemia) has been applied. Patients without early
complications are indeed at low risk, and it is reasonable to
discharge most of them, especially those who are younger
and those who have good social support, on or even before
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day five (i.e., four or even three days in the hospital).
Noninvasive testing to characterize left ventricular function
and the potential for recurrent ischemia, performed while
the patient is still in the hospital, can refine risk stratifica-
tion. The former seems particularly important when in-
creased heart rate, serial electrocardiograms, or enzyme
measurements indicate a relatively large infarct in an oth-
erwise stable patient; the latter seems so on general princi-
ple. It behooves us as stewards of patient welfare to
demonstrate that a patient whose coronary anatomy is
unknown can safely perform activities appropriate for the
first week or two at home. In addition, to the greatest extent
possible, patients going home early should be discharged on
beta-blockers. Ultimately, however, decisions should be
individualized, and social as well as clinical conditions
should be factored into the timing of discharge.
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